This treatment protocol consists of a total of 4 cycles of alternating epirubicin/cyclophosphamide with ifosfamide/etoposide in 28 day cycles. CT staging with MRI +/- PET after cycle 2.
Cycles 1 and 3
Cycles 2 and 4 (CT staging with MRI +/- PET after cycle 2)
To include an overview statement about the order of cycles.
Daily induction treatment is continued until bone marrow remission is achieved. If bone marrow remission is not achieved by day 60, treatment must be discontinued.
This treatment regimen consists of two parts: 4 cycles of AC followed by Weekly PACLItaxel and Three Weekly Trastuzumab
Exact cut and paste from current site
AC (DOXOrubicin and CYCLOPHOSPHamide)
PACLItaxel (Weekly) and Trastuzumab (Three Weekly)
Frequency: 21 days
Cycles: 4 (then continue trastuzumab for an additional 13 cycles ; total trastuzumab treatment to equal 52 weeks)
Send feedback for this page
The currency of this information is guaranteed only up until the date of printing, for any updates please check:
19 Nov 2019